Bill119th CongressFiled Feb 25, 2026Health
H.Res. 1079
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Feb 25, 2026)
This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.
What just happenedFeb 25, 2026
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Gottheimer, Josh [D-NJ-5](D-NJ)Sponsor
1 cosponsor1 R
1cosponsors1committees3actions
- Introduced in HouseFeb 25, 2026
- Feb 25, 2026IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 25, 2026IntroReferralH11100
Submitted in House
- Feb 25, 2026IntroReferral1025
Submitted in House